| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2016-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2020-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107759616-B |
| titleOfInvention |
Compound and preparation method and application thereof |
| abstract |
The invention discloses a compound with a structure shown in a formula I or pharmaceutically acceptable salt or halide thereof, and a preparation method and application thereof: wherein A represents a bond, -O-, -R X ‑、‑N(R X )‑、‑C(O)‑、‑N(R X )C(O)‑、‑N(R X )C(O)O‑、‑C(O)N(R X )‑、‑N(R X )C(O)N(R X )‑、‑OC(O)‑、‑C(O)O‑、‑OC(O)O‑、‑OC(O)N(R X )‑、‑S(O) 2 ‑、‑S(O) 2 N(R X )‑、‑OS(O) 2 N(R X )‑、‑N(R X )S(O) 2 -, or-OS (O) 2 O‑；R X Is C1-C8 alkyl optionally substituted with C1-C4 alkoxycarbonyl. |
| priorityDate |
2016-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |